709 related articles for article (PubMed ID: 12866281)
1. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
[No Abstract] [Full Text] [Related]
2. [Antihistaminics. Side effects also after raising dosage at the placebo level].
MMW Fortschr Med; 2003 May; 145(22):50-1. PubMed ID: 12866280
[No Abstract] [Full Text] [Related]
3. [Respiratory allergies in the child and the adult].
Magnan A
Rev Prat; 2004 Jan; 54(2):189-98. PubMed ID: 15086062
[No Abstract] [Full Text] [Related]
4. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of ebastine 10mg and 20mg once daily with that of cetirizine 10mg once daily in adults with seasonal allergic rhinitis. A multicentre double-blind study.
Cohen B; Gehanno P
Drugs; 1996; 52 Suppl 1():26-9. PubMed ID: 8828023
[No Abstract] [Full Text] [Related]
6. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
Day JH; Briscoe M; Widlitz MD
J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
[TBL] [Abstract][Full Text] [Related]
7. [Peripheral anticholinergic syndrome].
Valencia Zavala MP; Vega Robledo GB; Sánchez Olivas JA; Sánchez Olivas MA; Montes Montes J; Duarte Díaz RJ; León Oviedo C
Rev Alerg Mex; 2007; 54(2):66-9. PubMed ID: 17542247
[TBL] [Abstract][Full Text] [Related]
8. A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit - the Vienna Challenge Chamber (VCC).
Stübner P; Zieglmayer R; Horak F
Curr Med Res Opin; 2004 Jun; 20(6):891-902. PubMed ID: 15200748
[TBL] [Abstract][Full Text] [Related]
9. [Clinical research of Ibudilast on treating the steroid resistant allergic rhinitis].
Luo H; Tao Z; Yan N; Liang J; Wang P; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 23(2):63-6. PubMed ID: 19452709
[TBL] [Abstract][Full Text] [Related]
10. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
Salmun LM; Gates D; Scharf M; Greiding L; Ramon F; Heithoff K
Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
Gehanno P; Bremard-Oury C; Zeisser P
Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684
[TBL] [Abstract][Full Text] [Related]
13. Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis.
Ciprandi G; Tosca MA; Milanese M; Ricca V
Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):237-40. PubMed ID: 15329007
[TBL] [Abstract][Full Text] [Related]
14. Ebastine in perennial allergic rhinitis.
Picado Vallés C; Cadahia García A; Cisteró Bahima A; Cano Cantudo L; Sanz Amaro A; Zayas Sanza JM
Ann Allergy; 1991 Dec; 67(6):615-8. PubMed ID: 1684273
[TBL] [Abstract][Full Text] [Related]
15. A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
Van Cauwenberge P; De Belder T; Sys L
Expert Opin Pharmacother; 2004 Aug; 5(8):1807-13. PubMed ID: 15264995
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ebastine with cetirizine.
Volkerts ER
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):465-6. PubMed ID: 9396983
[No Abstract] [Full Text] [Related]
17. Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis.
Ratner P; Falqués M; Chuecos F; Esbrí R; Gispert J; Peris F; Luria X; Rosales MJ
Int Arch Allergy Immunol; 2005 Dec; 138(4):312-8. PubMed ID: 16224195
[TBL] [Abstract][Full Text] [Related]
18. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis.
Nunes C; Ladeira S
J Investig Allergol Clin Immunol; 2000; 10(1):20-3. PubMed ID: 10780795
[TBL] [Abstract][Full Text] [Related]
19. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.
Ratner PH; Lim JC; Georges GC
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1101-7. PubMed ID: 10856142
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
